Registrational Trials for the FDA Approval of Trilaciclib
May 13th 2021An expert in the management of small cell lung cancer gives an in-depth review of the study design, safety, and efficacy of the clinical trials that led to the FDA approval of trilaciclib for chemotherapy-induced myelosuppression.
Read More